
IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.
The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.
The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors.
Article excerpts from calcalisttech.com
The juicy tomato, a daily feature of the Israeli diet, may be helping keep Israelis healthy.
A group of researchers from Tel Aviv University has discovered how malignant tumors from melanoma, the deadly skin cancer, work. The group is led by a young lecturer and researcher, Dr. Carmit Levy.
The Second International Advisory Board Meeting and Symposium of the Raphael Recanati Genetic Institute, chaired by Prof. Moshe Garty was recently held at Rabin Medical Center.